<DOC>
	<DOCNO>NCT01359579</DOCNO>
	<brief_summary>The purpose study compare evaluate pharmacokinetic characteristic safety varespladib methyl mild moderate renal impairment patient healthy volunteer .</brief_summary>
	<brief_title>A Study Pharmacokinetics Safety Varespladib Subjects With Normal Impaired Renal Function</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Varespladib methyl</mesh_term>
	<criteria>Males nonpregnant , nonlactating female 18 year old BMI 1840 kg/m2 inclusive . Regarding renal function , subject classify either normal suffering mild , moderate severe renal impairment . Classification renal impairment estimate MDRD CockcroftGault formulae Any disease , condition and/or chronic medication might compromise hematologic , cardiovascular , pulmonary renal , gastrointestinal , hepatic , central nervous system ; condition might interfere distribution , metabolism excretion study drug , would place subject increase risk Evidence significant respiratory , gastrointestinal hepatic disease screen Positive screen hepatitis B surface antigen , HIV Positive test drug abuse screen alcohol admission clinic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>renal impairment</keyword>
	<keyword>phase 1</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>